Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5259602, 13 pages
http://dx.doi.org/10.1155/2016/5259602
Review Article

Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis

1Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
2Department of Children Rehabilitation Medicine, Guangxi Maternal and Child Health Hospital, 225 Xinyang Road, Nanning, Guangxi Zhuang Autonomous Region 530003, China
3Center of Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China

Received 15 September 2015; Accepted 27 March 2016

Academic Editor: Ja Hyeon Ku

Copyright © 2016 Xiaoning Gan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Xiaoning Gan, Xiaomiao Lin, Rongquan He, et al., “Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis,” Disease Markers, vol. 2016, Article ID 5259602, 13 pages, 2016. https://doi.org/10.1155/2016/5259602.